Shire prevails in Mydayis patent challenge Seeking Alpha
Takeda’s (TAK +0.2%) Shire plc is the winner of a challenge to two patents protecting long-acting ADHD med Mydayis by a would-be generic competitor.
Shire prevails in Mydayis patent challenge Seeking Alpha
Takeda’s (TAK +0.2%) Shire plc is the winner of a challenge to two patents protecting long-acting ADHD med Mydayis by a would-be generic competitor.